Keebeck Alpha, LP Johnson & Johnson Transaction History

Keebeck Alpha, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 01, 2023	BUY	$168.19 - $186.01 $88,299 - $97,655	525 Added 13.4%	4,442 $788,000
Q2 2022 Aug 08, 2022	BUY	$168.19 - $186.01 $88,299 - $97,655	525 Added 13.4%	4,442 $788,000
Q1 2022 Feb 01, 2023	SELL	$158.14 - $179.59 $83,023 - $94,284	-525 Reduced 11.82%	3,917 $694,000
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $203,644 - $225,951	1,306 Added 50.02%	3,917 $670,000
Q4 2020 Feb 05, 2021	BUY	$137.11 - $157.38 $357,994 - $410,919	2,611 New	2,611 $411,000

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.